These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 23808938)
1. Aberrant cytokeratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinoma. Yamagishi H; Imai Y; Okamura T; Fukuda K; Ono Y; Ban S; Inoue T; Ueda Y J Gastroenterol Hepatol; 2013 Dec; 28(12):1815-22. PubMed ID: 23808938 [TBL] [Abstract][Full Text] [Related]
2. Differential mucin phenotypes and their significance in a variation of colorectal carcinoma. Imai Y; Yamagishi H; Fukuda K; Ono Y; Inoue T; Ueda Y World J Gastroenterol; 2013 Jul; 19(25):3957-68. PubMed ID: 23840140 [TBL] [Abstract][Full Text] [Related]
3. Expression of cytokeratin 20 indicates invasive histological phenotype in poorly differentiated colorectal adenocarcinoma. Imai Y; Yamagishi H; Fukuda K; Okamura T; Ono Y; Ban S; Inoue T; Ueda Y Anticancer Res; 2014 Jan; 34(1):159-67. PubMed ID: 24403457 [TBL] [Abstract][Full Text] [Related]
4. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: I. Cytokeratin profile in 42 cases. Terada T Int J Clin Exp Pathol; 2013; 6(4):703-10. PubMed ID: 23573317 [TBL] [Abstract][Full Text] [Related]
5. CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma. Shin JH; Bae JH; Lee A; Jung CK; Yim HW; Park JS; Lee KY Jpn J Clin Oncol; 2010 Mar; 40(3):208-13. PubMed ID: 19926591 [TBL] [Abstract][Full Text] [Related]
6. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary. Vang R; Gown AM; Zhao C; Barry TS; Isacson C; Richardson MS; Ronnett BM Am J Surg Pathol; 2007 Jun; 31(6):854-69. PubMed ID: 17527072 [TBL] [Abstract][Full Text] [Related]
7. Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas. Bayrak R; Yenidünya S; Haltas H Pathol Res Pract; 2011 Mar; 207(3):156-60. PubMed ID: 21282015 [TBL] [Abstract][Full Text] [Related]
8. Cytokeratin 7 and 20 expression in gallbladder carcinoma. Kalekou H; Miliaras D Pol J Pathol; 2011; 62(1):25-30. PubMed ID: 21574103 [TBL] [Abstract][Full Text] [Related]
9. Tubular carcinoids of the appendix: the CK7/CK20 immunophenotype can be a diagnostic pitfall. Matsukuma KE; Montgomery EA J Clin Pathol; 2012 Jul; 65(7):666-8. PubMed ID: 22461652 [TBL] [Abstract][Full Text] [Related]
10. Identification of relevant prognostic values of cytokeratin 20 and cytokeratin 7 expressions in lung cancer. Luo HT; Liang CX; Luo RC; Gu WG Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28827446 [TBL] [Abstract][Full Text] [Related]
11. Cytokeratin expression profiling in gastric carcinoma: clinicopathologic significance and comparison with tumor-associated molecules. Takami H; Sentani K; Matsuda M; Oue N; Sakamoto N; Yasui W Pathobiology; 2012; 79(3):154-61. PubMed ID: 22286119 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical staining of cytokeratin 20 and cytokeratin 7 in colorectal carcinomas: Four different immunostaining profiles. Al-Maghrabi J; Emam E; Gomaa W Saudi J Gastroenterol; 2018; 24(2):129-134. PubMed ID: 29637921 [TBL] [Abstract][Full Text] [Related]
13. Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status. Lugli A; Tzankov A; Zlobec I; Terracciano LM Mod Pathol; 2008 Nov; 21(11):1403-12. PubMed ID: 18587323 [TBL] [Abstract][Full Text] [Related]
14. CK20 and CK7 protein expression in colorectal cancer: demonstration of the utility of a population-based tissue microarray. Hernandez BY; Frierson HF; Moskaluk CA; Li YJ; Clegg L; Cote TR; McCusker ME; Hankey BF; Edwards BK; Goodman MT Hum Pathol; 2005 Mar; 36(3):275-81. PubMed ID: 15791572 [TBL] [Abstract][Full Text] [Related]
15. [Clinicopathologic characteristics and histogenesis of mucinous tumor of peritoneum]. Zhang H; Sun Y; Huang X; Jia L; Bai Y; Cao D Zhonghua Bing Li Xue Za Zhi; 2014 Mar; 43(3):163-8. PubMed ID: 24842014 [TBL] [Abstract][Full Text] [Related]
16. Cytokeratin 7 expression as a predictor of an unfavorable prognosis in colorectal carcinoma. Hrudka J; Fišerová H; Jelínková K; Matěj R; Waldauf P Sci Rep; 2021 Sep; 11(1):17863. PubMed ID: 34504224 [TBL] [Abstract][Full Text] [Related]
17. [Diagnostic value of SATB2, CK7 and CK20 in colorectal cancer]. Lyn J; Wang Y; Wang F; Shen M; Zhou X Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):578-81. PubMed ID: 26705182 [TBL] [Abstract][Full Text] [Related]
18. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary. Park SY; Kim HS; Hong EK; Kim WH Hum Pathol; 2002 Nov; 33(11):1078-85. PubMed ID: 12454811 [TBL] [Abstract][Full Text] [Related]
19. BRAF-mutated microsatellite stable colorectal carcinoma: an aggressive adenocarcinoma with reduced CDX2 and increased cytokeratin 7 immunohistochemical expression. Landau MS; Kuan SF; Chiosea S; Pai RK Hum Pathol; 2014 Aug; 45(8):1704-12. PubMed ID: 24908142 [TBL] [Abstract][Full Text] [Related]
20. Aberrant pattern of the cytokeratin 7/cytokeratin 20 immunophenotype in colorectal adenocarcinomas with BRAF mutations. Gurzu S; Jung I Pathol Res Pract; 2012 Mar; 208(3):163-6. PubMed ID: 22361037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]